BackCelldex Therapeutics Overview
Celldex Therapeutics Inc.

Celldex Therapeutics Target Price

Where could CLDX trade next? Consensus target price: $64.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.93

Average Target Price

$63.92113.6% upside

13 analysts in the last 4 months

High: $100 | Low: $40

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-23Leerink PartnersThomas Smith$88194% upsideOpen
2026-09-23Morgan Stanley$5790.4% upsideOpen
2026-09-22Stifel NicolausAlex Thompson$68127.2% upsideOpen
2026-09-22H.C. WainwrightJoseph Pantginis$64113.8% upsideOpen
2026-09-10Morgan StanleyJudah Frommer$5067.1% upsideOpen
2026-08-07Barclays$5377.1% upsideOpen
2026-07-29Wells Fargo$72140.6% upsideOpen
2026-07-22Cantor Fitzgerald$61103.8% upsideOpen
2026-07-22Wells Fargo$4860.4% upsideOpen
2026-07-22Morgan Stanley$4033.6% upsideOpen
2026-07-22Canaccord Genuity$60100.5% upsideOpen
2026-07-22Leerink Partners$70133.9% upsideOpen
2026-07-20GuggenheimYatin Suneja$100234.1% upsideOpen
2026-06-10UBS$4550.4% upsideOpen
2026-05-13Wells FargoDerek Archila$5480.4% upsideOpen
2026-05-08Barclays$4860.4% upsideOpen
2026-04-20Barclays$4550.4% upsideOpen
2025-12-17Barclays$2419.8% downsideOpen
2025-11-11Barclays$2129.8% downsideOpen
2025-10-13Barclays$2516.5% downsideOpen
2025-03-20Morgan Stanley$4653.7% upsideOpen
2024-10-29H.C. WainwrightJoseph Pantginis$80167.3% upsideOpen
2024-09-25Wells FargoDerek Archila$4447% upsideOpen
2024-06-17Stifel NicolausAlex Thompson$5893.8% upsideOpen
2023-11-10Wells FargoDerek Archila$279.8% downsideOpen
2022-11-11Guggenheim$63110.5% upsideOpen

Celldex Therapeutics (CLDX) FAQ

The latest target price for CLDX is $64. Investors often review this figure alongside Celldex Therapeutics's historical trend and sector peers before judging valuation or financial health.

Celldex Therapeutics trades near $29.93 while the consensus target sits at $64 (113.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CLDX's target price ($64), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Celldex Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.